1CM Inc.

CNSX:EPIC 株式レポート

時価総額:CA$29.4m

1CM 過去の業績

過去 基準チェック /06

1CM has been growing earnings at an average annual rate of 55%, while the Pharmaceuticals industry saw earnings growing at 46% annually. Revenues have been growing at an average rate of 85% per year.

主要情報

55.0%

収益成長率

57.8%

EPS成長率

Pharmaceuticals 業界の成長23.1%
収益成長率85.0%
株主資本利益率-2.1%
ネット・マージン-1.1%
前回の決算情報31 May 2024

最近の業績更新

Recent updates

1CM Inc. (CSE:EPIC) Might Not Be As Mispriced As It Looks After Plunging 30%

Sep 29
1CM Inc. (CSE:EPIC) Might Not Be As Mispriced As It Looks After Plunging 30%

1CM Inc. (CSE:EPIC) Stock's 32% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Aug 15
1CM Inc. (CSE:EPIC) Stock's 32% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Not Many Are Piling Into 1CM Inc. (CSE:EPIC) Stock Yet As It Plummets 32%

Jun 16
Not Many Are Piling Into 1CM Inc. (CSE:EPIC) Stock Yet As It Plummets 32%

Why We're Not Concerned Yet About 1CM Inc.'s (CSE:EPIC) 33% Share Price Plunge

Apr 27
Why We're Not Concerned Yet About 1CM Inc.'s (CSE:EPIC) 33% Share Price Plunge

What You Can Learn From 1CM Inc.'s (CSE:EPIC) P/S

Feb 07
What You Can Learn From 1CM Inc.'s (CSE:EPIC) P/S

Investors Appear Satisfied With 1CM Inc.'s (CSE:EPIC) Prospects

Jun 27
Investors Appear Satisfied With 1CM Inc.'s (CSE:EPIC) Prospects

収支内訳

1CM の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

CNSX:EPIC 収益、費用、利益 ( )CAD Millions
日付収益収益G+A経費研究開発費
31 May 2452-180
29 Feb 2446-170
30 Nov 2340-270
31 Aug 2335-160
31 May 2324-270
28 Feb 2315-360
30 Nov 228-340
31 Aug 221-530
31 May 221-540
28 Feb 221-550
30 Nov 211-540
31 Aug 210-540
31 May 210-420
28 Feb 210-310
30 Nov 200-310
31 Aug 200-310
31 May 200-2810
29 Feb 200-2810
30 Nov 190-2810
31 Aug 190-2910
31 May 190-750
28 Feb 190-860
30 Nov 180-760
31 Aug 180-660
31 May 180-220
28 Feb 180000
30 Nov 170000
31 Aug 170000
31 May 170000
28 Feb 170000
30 Nov 160000
31 Aug 160000
31 May 160-100
29 Feb 160-100
30 Nov 150-100
31 Aug 150-100
31 May 150-100
28 Feb 150000
30 Nov 140-200

質の高い収益: EPIC is currently unprofitable.

利益率の向上: EPIC is currently unprofitable.


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: EPIC is unprofitable, but has reduced losses over the past 5 years at a rate of 55% per year.

成長の加速: Unable to compare EPIC's earnings growth over the past year to its 5-year average as it is currently unprofitable

収益対業界: EPIC is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-40.8%).


株主資本利益率

高いROE: EPIC has a negative Return on Equity (-2.06%), as it is currently unprofitable.


総資産利益率


使用総資本利益率


過去の好業績企業の発掘